Sullivan Lynne Marie, CFO and Head of Corporate Development at Unity Biotechnology ($UNBX), sold shares once on the open market in the last year for a total of $22,523. Her most recent sale occurred on April 2, 2025. These sales rank her 10,971st out of 11,678 insiders by amount sold, well below the average of $8.6 million across 6.37 transactions per insider. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Solid Biosciences Inc. | $SLDB | Sullivan Lynne Marie | Not found | A | Director Stock Option (Right to Buy) | 77500 | $0.00 | 77,500.0000 | 40,816,694 | 9999.99% | 0.19% |
| April 2, 2025 | Unity Biotechnology, Inc. | $UNBX | Sullivan Lynne Marie | CFO & Head of Corp. Dev. | S | Common Stock, $0.0001 par value | 21867 | $1.03 | 98,905.0000 | 16,867,647 | 18.11% | 0.13% |
| March 28, 2025 | Unity Biotechnology, Inc. | $UNBX | Sullivan Lynne Marie | CFO & Head of Corp. Dev. | A | Common Stock, $0.0001 par value | 65000 | $0.00 | 120,772.0000 | 16,867,647 | 116.55% | 0.39% |
| March 28, 2025 | Unity Biotechnology, Inc. | $UNBX | Sullivan Lynne Marie | CFO & Head of Corp. Dev. | A | Stock Option (Right to Buy) | 106000 | $0.00 | 106,000.0000 | 16,867,647 | 9999.99% | 0.63% |
| Feb. 4, 2025 | Unity Biotechnology, Inc. | $UNBX | Sullivan Lynne Marie | CFO & Head of Corp. Dev. | S | Common Stock, $0.0001 par value | 153 | $2.23 | 55,772.0000 | 0 | 0.27% | 0.00% |
| Jan. 22, 2025 | Unity Biotechnology, Inc. | $UNBX | Sullivan Lynne Marie | CFO & Head of Corp. Dev. | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 4, 2024 | Unity Biotechnology, Inc. | $UNBX | Sullivan Lynne Marie | CFO & Head of Corp. Dev. | S | Common Stock, $0.0001 par value | 136 | $1.29 | 55,925.0000 | 0 | 0.24% | 0.00% |
| Aug. 2, 2024 | Unity Biotechnology, Inc. | $UNBX | Sullivan Lynne Marie | CFO & Head of Corp. Dev. | S | Common Stock, $0.0001 par value | 139 | $1.53 | 56,061.0000 | 0 | 0.25% | 0.00% |
| June 25, 2024 | Unity Biotechnology, Inc. | $UNBX | Sullivan Lynne Marie | CFO & Head of Corp. Dev. | S | Common Stock, $0.0001 par value | 324 | $1.40 | 32,685.0000 | 0 | 0.98% | 0.00% |
| June 11, 2024 | Solid Biosciences Inc. | $SLDB | Sullivan Lynne Marie | Not found | A | Director Stock Option (Right to Buy) | 34400 | $0.00 | 34,400.0000 | 19,884,007 | 9999.99% | 0.17% |